Dr. Kalani Lukela Raphael, MD

Dr. Raphael practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. Raphael's NPI, 1902982382, was assigned on October 28, 2006. Dr. Raphael graduated from University of Hawaii John A. Burns School of Medicine in 2002. Dr. Raphael holds Utah license 5525877-1205.

Dr. Raphael's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. Raphael's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Raphael is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Raphael practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Raphael's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Raphael's licenses on file in 2 states: Utah and Oregon.

CMS data shows 64 Medicare services from Dr. Raphael across 2 procedure codes in 2024, for 25 Medicare patients. Medicare paid $6,503 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 25 Medicare patients who saw Dr. Raphael in 2024. The largest group is 65 to 74, with 11 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. Their average risk score is 3.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Raphael's median patient age at 69, with 25% women.

In 2022, Dr. Raphael wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $114 in total drug cost. In 2021, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Raphael for performance year 2024, reported as part of a group. Dr. Raphael accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 67 papers to Dr. Raphael, published from 2010 to 2024. 2020 was the busiest year, with 8. The most frequent topics are Renal Insufficiency, Chronic, Glomerular Filtration Rate and Bicarbonates. Dr. Raphael has published most often in Clin J Am Soc Nephrol. Dr. Raphael's most frequent co-authors are Joachim Hanno Ix, MD, Srinivasan Beddhu, MD and Michel B. Chonchol, MD.

Dmand AI links Dr. Raphael to 3 clinical trials. Conditions studied include Renal Insufficiency, Chronic and Renal Insufficiency.

CMS Open Payments shows 1 general payment to Dr. Raphael from 1 drug or device company in 2020. Consulting fees make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,556.

Dr. Raphael graduated from University of Hawaii John A. Burns School of Medicine in 2002.